Real-world efficacy and adverse events of frontline nilotinib in pediatric chronic myeloid leukemia in chronic phase: A prospective multicenter study from SCCCG[PLUS]-CML 2023
一线尼洛替尼治疗慢性期儿童慢性粒细胞白血病的真实世界疗效和不良事件：来自 SCCCG[PLUS]-CML 2023 的前瞻性多中心研究
期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.70225
Fan, Zhong; Chen, Qi-Wen; Huang, Xiu-Ya; Fu, Qiang; Mai, Hui-Rong; Long, Xing-Jiang; Li, Qiao-Ru; Liu, Li-Li; Liu, Ri-Yang; He, Fei; Guo, Bi-Yun; Zeng, Min-Hui; Wan, Wu-Qing; Zhang, Wei-Na; Guo, Hai-Xia; Zhou, Dun-Hua; Zou, Ya-Wei; Xiong, Wen-Jie; Zhou, Xiao-Bo; Chen, Hui-Qin; Lin, Li-Min; Ren, Hao-Yan; Tian, Xin; Wei, Hong-Ying; Lan, He-Kui; Jin, Jiao; Liang, Cong; Luo, Xue-Qun; Huang, Li-Bin; Yang, Li-Hua; Zhang, Xiao-Li
